New chiral blocks for introducing the side chain of HMG-CoA reductase inhibitors
- 1 July 1992
- journal article
- Published by Elsevier in Tetrahedron Letters
- Vol. 33 (29) , 4183-4186
- https://doi.org/10.1016/s0040-4039(00)74684-3
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Diastereoselection in the addition of enolates to chiral α,β-epoxyaldehydesTetrahedron Letters, 1991
- Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductaseJournal of Medicinal Chemistry, 1991
- Stereoselective synthesis of HR 780 a new highly potent HMG-CoA reductase inhibitorTetrahedron Letters, 1990
- Synthesis, biological profile, and quantitative structure-activity relationship of a series of novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsJournal of Medicinal Chemistry, 1990
- 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 6. trans-6-[2-(Substituted-1-naphthyl)ethyl(or ethenyl)]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-onesJournal of Medicinal Chemistry, 1990
- A highly stereoselective route to the four stereoisomers of a six-carbon synthonTetrahedron: Asymmetry, 1990
- Synthesis and biological activity of new HMG-CoA reductase inhibitors. 2. Derivatives of 7-(1H-pyrrol-3-yl)-substituted-3,5-dihydroxyhept-6(E)-enoic (-heptanoic) acidsJournal of Medicinal Chemistry, 1990
- Asymmetric synthesis via acetal templates. 15. The preparation of enantiomerically pure mevinolin analogsTetrahedron Letters, 1988
- Synthesis of an HMG-CoA reductase inhibitor; a diastereoselective aldol approachTetrahedron Letters, 1987
- The synthesis of mevinic acidsTetrahedron, 1986